Literature DB >> 26621484

Response to: 'Heterogeneity, consistency and model fit should be assessed in Bayesian network meta-analysis' by Wei et al.

Michael M Ward1, Abhijit Dasgupta1, Runsheng Wang1.   

Abstract

Entities:  

Keywords:  Disease Activity; Patient perspective; Treatment

Mesh：

Substances：

Year:  2015        PMID： 26621484      PMCID： PMC5075426          DOI： 10.1136/annrheumdis-2015-208670

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1.  Heterogeneity, consistency and model fit should be assessed in Bayesian network meta-analysis.

Authors:  Jie Wei; Chao Zeng; Guang-Hua Lei
Journal:  Ann Rheum Dis       Date:  2015-10-15       Impact factor: 19.103

2.  ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis.

Authors:  Maxime Dougados; Paternotte Simon; Juergen Braun; Ruben Burgos-Vargas; Walter P Maksymowych; Joachim Sieper; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2010-09-09       Impact factor: 19.103

3.  Checking consistency in mixed treatment comparison meta-analysis.

Authors:  S Dias; N J Welton; D M Caldwell; A E Ades
Journal:  Stat Med       Date:  2010-03-30       Impact factor: 2.373

4.  Comparative efficacy of non-steroidal anti-inflammatory drugs in ankylosing spondylitis: a Bayesian network meta-analysis of clinical trials.

Authors:  Runsheng Wang; Abhijit Dasgupta; Michael M Ward
Journal:  Ann Rheum Dis       Date:  2015-08-06       Impact factor: 19.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.